RedShift BioAnalytics

RedShift BioAnalytics

Provides a next-generation infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery.

Launch date
Employees
Market cap
-
Enterprise valuation
€73—109m (Dealroom.co estimates Oct 2021.)
Burlington Vermont (HQ)
Authorizing premium user...